Tino Gaberthüel_Patrick Schärli

Lenz & Staehelin: Novartis Successfully Spins Off Sandoz 

On October 4, 2023, Novartis successfully executed the spin-off of Sandoz by distributing Sandoz shares as a dividend-in-kind to Novartis shareholders and American Depositary Receipts (ADRs) holders. Sandoz shares are now listed on the SIX Swiss Exchange. 

Lenz & Staehelin, represented by Tino Gaberthüel and Patrick Schärli, provided advisory services to Gordon Dyal & Co., the financial advisor to Novartis, throughout this transaction. 

Suzan Abdien Hago Taha

SHARE